Skip to content

Clinical trials

Phase 2/3 Depressive Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Depressive Disorder Phase: Phase 2/3 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20081
20091
20102
20121
20141
20152
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Pittsburgh2
Bo Hu1
Chinese University of Hong Kong1
Kyoto University1
Markus KOSEL1
Nagoya City University1
Pouya Movahed Rad1
Praxis Precision Medicines1
Stanford University1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Depressive Disorder14
Major Depressive Disorder7
Bipolar Disorder2
Mood Disorders2
Anxiety Disorders1
Cardiovascular Diseases1
Depressive Disorder, Treatment-Resistant1
Heart Failure, Systolic1
Mental Disorders1
Psychotic Disorders1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.